We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 887 results
  1. Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation

    Background

    Cardiovascular diseases, including diabetic cardiomyopathy, are major causes of death in people with type 2 diabetes. Aldose reductase...

    Keshav Gopal, Qutuba G. Karwi, ... Gary D. Lopaschuk in Cardiovascular Diabetology
    Article Open access 28 March 2023
  2. Comparative Evaluation of Aldose Reductase Inhibition in Polycystic Ovarian Syndrome–Induced Rats

    Polycystic ovary syndrome (PCOS) represents a spectrum of disorders, associated with hyperandrogenism, oligoanovulation, and polycystic ovaries....

    Roshni Patel, Zarna Pathak, ... Gaurang Shah in Reproductive Sciences
    Article 05 August 2022
  3. Syzygium aromaticum bud (clove) essential oil is a novel and safe aldose reductase inhibitor: in silico, in vitro, and in vivo evidence

    Purpose

    This study aimed to evaluate the antioxidant and antidiabetic properties of clove essential oil (CEO) and to elucidate its mode of action,...

    Imane Nait Irahal, Ismail Guenaou, ... Noureddine Bourhim in Hormones
    Article 25 February 2022
  4. Carica papaya Linn. fruit extract inhibited the activities of aldose reductase and sorbitol dehydrogenase: possible mechanism for amelioration of diabetic complications

    Background

    Diabetes mellitus is a metabolic disorder which is associated with debilitating complications including eye disease, kidney disorder, and...

    Mutiu Idowu Kazeem, Ayotomiwa Adeyinka Adeyemi, ... Mushafau Adewale Akinsanya in Future Journal of Pharmaceutical Sciences
    Article Open access 22 November 2020
  5. Cheminformatics identification of modulators of key carbohydrate-metabolizing enzymes from C. cujete for type-2 diabetes mellitus intervention

    Purpose

    The therapeutic use of oral hypoglycaemic agents in the management of type-2 diabetes mellitus (T2DM) is without adverse effects; thus, calls...

    Fatai Oladunni Balogun, Karishma Singh, ... Saheed Sabiu in Journal of Diabetes & Metabolic Disorders
    Article Open access 01 July 2023
  6. Two rare flavonoid glycosides from Litsea glutinosa (Lour.) C. B. Rob.: experimental and computational approaches endorse antidiabetic potentiality

    Background

    Litsea glutinosa (Lour.) C. B. Rob. belongs to the Litsea genus and is categorized under the family of Lauraceae . The study aimed to...

    Israt Jahan Bulbul, Md. Jamal Hossain, ... Mohammad A. Rashid in BMC Complementary Medicine and Therapies
    Article Open access 01 February 2024
  7. Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial

    Background

    Diabetic cardiomyopathy (DbCM) is a form of Stage B heart failure (HF) at high risk for progression to overt disease. Using baseline...

    James L. Januzzi, Stefano Del Prato, ... Riccardo Perfetti in Cardiovascular Diabetology
    Article Open access 01 February 2024
  8. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference

    Purpose of Review

    To summarize selected late-breaking science on cardiovascular (CV) disease prevention presented at the 2024 Scientific Session of...

    Kartik Gupta, Bharat Rawlley, ... Salim S. Virani in Current Atherosclerosis Reports
    Article 03 June 2024
  9. Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury?

    A novel class of oral glucose lowering drugs, sodium-glucose co-transporter type 2 inhibitors (SGLT2is), has shown additional beneficial effects on...

    Sidar Copur, Abdullah Yildiz, ... Mehmet Kanbay in Journal of Nephrology
    Article 13 August 2022
  10. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

    Vascular complications of diabetes pose a severe threat to human health. Prevention and treatment protocols based on a single vascular complication...

    Yiwen Li, Yanfei Liu, ... Yue Liu in Signal Transduction and Targeted Therapy
    Article Open access 10 April 2023
  11. Evaluating treatment options for cardiovascular autonomic neuropathy in patients with diabetes mellitus: a systematic review

    Background

    Cardiovascular autonomic neuropathy (CAN) is a debilitating complication of diabetes mellitus. To date, there is no systematic review on...

    Jasmine KaiLi Goh, Leroy Koh in Diabetology International
    Article 25 April 2023
  12. Plant bioactive compounds and their mechanistic approaches in the treatment of diabetes: a review

    Background

    Diabetes mellitus (DM) is a growing disease across the world; diabetes is a complex metabolic disorder in which blood glucose concentration...

    Anshika, Rupesh Kumar Pandey, ... Shruti Jain in Future Journal of Pharmaceutical Sciences
    Article Open access 09 December 2022
  13. Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-induced Diabetic Rats

    Epalrestat, an aldose reductase inhibitor (ARI), was adopted to improve the function of peripheral nerves in diabetic patients. The aim of this study...

    Bai-Bing Yang, Zhi-Wei Hong, ... Yu-Tian Dai in International Journal of Impotence Research
    Article Open access 13 September 2018
  14. Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies

    The global pandemic of prediabetes and diabetes has led to a severe corresponding complication of these disorders. Neuropathy is one of the most...

    Komal Arora, Pushpa C. Tomar, Vandana Mohan in Journal of Diabetes & Metabolic Disorders
    Article 25 June 2021
  15. Congenital disorders of glycosylation: narration of a story through its patents

    Congenital disorders of glycosylation are a group of more than 160 rare genetic defects in protein and lipid glycosylation. Since the first clinical...

    Maria Monticelli, Tania D’Onofrio, ... Maria Vittoria Cubellis in Orphanet Journal of Rare Diseases
    Article Open access 29 August 2023
  16. Fructose might be a clue to the origin of preeclampsia insights from nature and evolution

    Preeclampsia is a hypertensive disorder of pregnancy and is due to abnormal placentation. The pathogenesis remains unclear. Fructose is biologically...

    Takahiko Nakagawa, Ana Andres-Hernando, ... Richard J. Johnson in Hypertension Research
    Article 20 December 2022
  17. Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10)

    Aim/introduction

    This study aims to investigate the prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy (DSPN) in...

    Hideki Kamiya, Tatsuhito Himeno, ... Jiro Nakamura in Diabetology International
    Article 12 January 2024
  18. Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction

    Diabetes mellitus is a chronic metabolic disease, posing a considerable threat to global public health. Treating systemic comorbidities has been one...

    Qi-**ang Song, Yi Sun, ... Margot S. Damaser in Nature Reviews Urology
    Article 16 August 2022
  19. Correction: Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-induced Diabetic Rats

    This Article was originally published under Nature Research’s License to Publish, but has now been made available under a CC BY 4.0 license. The PDF...

    Bai-Bing Yang, Zhi-Wei Hong, ... Yu-Tian Dai in International Journal of Impotence Research
    Article Open access 04 February 2019
  20. Flubendazole carbonyl reduction in drug-susceptible and drug-resistant strains of the parasitic nematode Haemonchus contortus: changes during the life cycle and possible inhibition

    Carbonyl-reducing enzymes (CREs) catalyse the reduction of carbonyl groups in many eobiotic and xenobiotic compounds in all organisms, including...

    Nikola Rychlá, Martina Navrátilová, ... Lenka Skálová in Veterinary Research
    Article Open access 15 January 2024
Did you find what you were looking for? Share feedback.